Related Experiment Video
Updated: Jun 8, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.4K
MRI graph parameters are longitudinal markers of neuronal integrity in multiple sclerosis
Milad Hamwi1, Simon Thebault2, Gerd Melkus3
1Ottawa Hospital Research Institute; University of Ottawa, Department of Radiology, Radiation Oncology and Medical Physics.
Multiple Sclerosis and Related Disorders
|November 4, 2024
Summary
Structural network parameters offer new insights into multiple sclerosis (MS) treatment response after immunoablation and autologous haemopoietic stem cell transplantation (IAHSCT). These markers better predict neuronal injury than traditional methods.
Area of Science:
- Neuroscience
- Medical Imaging
- Immunology
Background:
- Multiple Sclerosis (MS) is a chronic neurological disease.
- Immunoablation and autologous haemopoietic stem cell transplantation (IAHSCT) is a treatment for MS.
- Understanding treatment response and disease progression is crucial.
Purpose of the Study:
- To determine if structural network parameters improve prediction of MS treatment response post-IAHSCT.
- To investigate cortical changes in progressive MS after suppressing relapsing biology.
Main Methods:
- Analysis of a phase 2 prospective study involving 24 MS patients.
- Assessment of magnetic resonance graph parameters, N-acetylaspartate to creatine ratio (NAA/Cr), and serum neurofilament light chain (sNfL) pre- and post-IAHSCT.
- Correlation and multivariate analyses to evaluate model improvements.
Main Results:
- Post-IAHSCT, higher NAA/Cr and lower sNfL correlated with more favorable network parameters.
- Changes in network parameters (degree, path length, γ) were associated with NAA/Cr and sNfL.
- Network parameters explained 14% and 35% more variance in NAA/Cr and sNfL, respectively, than traditional models.
Conclusions:
- Structural network parameters are valuable markers for MS disease severity.
- These parameters can capture cortical changes relevant to progressive, non-relapsing MS biology.
- Network analysis offers added utility beyond traditional markers for MS treatment response.

